UNSPSC 51453303: Sulbentine

This classification denotes an antifungal agent with the molecular formula C17H18N2S2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier D0NR12WK9J, chemically known as 3,5-dibenzyltetrahydro-2h-1,3,5-thiadiazine-2-thione but more generally known as dibenzthion, which bears U.S. NIH Compound Identifier 67686. European Medicines Agency schedules Sulbentine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10678MIG.

The term SULBENTINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 22, No. 10, 1968, List 8). World Health Organization schedules dibenzthion in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary.

UNSPSC 51453303 Sulbentine is a Commodity code under which state and local governments procure pharmaceutical products and related health-supply items for public health and emergency-response programs. Recent solicitations show state health departments and county health authorities buying specific pharmaceutical inventory — antibiotics, opioid-reversal agents, and ancillary medical supplies — through both direct procurement and cooperative purchasing vehicles. The work spans routine pharmaceutical warehouse supply contracts and targeted procurement for community health and emergency-preparedness initiatives, often with quarterly or annual delivery schedules and multi-year terms including renewal options.

Activity under this code appears concentrated in Florida and Illinois, with the most recent opportunities posted in mid-2026 and early 2023. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 (Bid Number 26-482DPH-PREPD-B-53392, response deadline September 11, 2026) for supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets, with a total contract value of $2,999,999.11 over three years. Seminole County, Florida issued an IFB (IFB60459723LAS, posted June 30, 2026, response deadline July 26, 2023) seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the procurement included E-Verify compliance and potential FEMA funding. Both opportunities emphasize delivery logistics, multi-year terms, and fixed-fee pricing structures.